Material Topics

CSL’s Global CR Committee has overall responsibility for the materiality process and executes a global materiality assessment on a biennial basis. In 2019/20, we concluded our fourth assessment and followed the Global Reporting Initiative (GRI) standards of sustainability context, materiality, completeness and stakeholder inclusiveness through our process of identification, review and prioritisation. The application and disclosure of our materiality process against the GRI materiality principle definition was subject to limited external assurance by Ernst & Young.

Our fourth materiality assessment provided coverage across the CSL group of businesses, including Seqirus, but excludes the acquisition of Vitaeris, a biotech company, that was announced in June 2020.

CSL fourth materiality assessment is the result of detailed internal and external stakeholder feedback to help identify topics most important to them and CSL, including the environment and society. The process involved dialogue with employees; heads of function, such as CSL leaders responsible for product safety and quality, talent attraction, supplier management, corporate governance, research and development, investor relations and employee health and safety; CSL’s Global Leadership Group; and a number of external stakeholders including investors, healthcare providers (customers)  and government representatives. The results of the internal assessment were overlayed with external benchmarking of peer organisations and leaders in the industry, a media scan and the material topics of leading sustainability indices providers such as SASB and DJSI.  The results were aggregated by topic and scored, based on prevalence, for ranking and prioritisation purposes. Minor refinements were made to the final list following a review by CSL’s CR Steering Committee such as the consolidation of environmental topics and the resulting inclusion of donors in the top ranked topics. 

 

Rank

CSL’s top sustainability material topics

1

Product safety and quality (A)

2

Talent recruitment, development and retention (B)

3

Access to healthcare (C)

4

Environment – resource consumption and environmental protection (D)

5

Health and safety (E)

6

Innovation/R&D (F)

7

Communities we operate in (G)

8

Corporate governance (H)

9

Climate change risk (I)

10

Social investment (J1)

Diversity and inclusion (J2)

Human rights/labour practices (J3)

Integrity (J4)

Donors (J5)